ATHENA CRAVEN: Open Payments
NPI 1316495187 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 32 payments from 10 companies in 2025. Trend: 2023 $67 · 2024 $393 · 2025 $969
Food & beverage: $864Education: $105
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $225 |
| LEO Pharma Inc. | 2 | $200 |
| Galderma Laboratories, L.P. | 4 | $188 |
| Regeneron Healthcare Solutions, Inc. | 6 | $179 |
| ABBVIE INC. | 3 | $52 |
| Arcutis Biotherapeutics, Inc. | 2 | $46 |
| Lilly USA, LLC | 1 | $24 |
| Incyte Corporation | 1 | $19 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
| Botanix SB Inc | 1 | $17 |
Products named: DUPIXENT, NEMLUVIO, ANZUPGO, ADBRY, Zoryve, SKYRIZI, TALTZ, OPZELURA.
Industry payments across TX — which companies pay providers there.
